Literature DB >> 31838870

Individual Patterns of Abnormality in Resting-State Functional Connectivity Reveal Two Data-Driven PTSD Subgroups.

Adi Maron-Katz1, Yu Zhang1, Manjari Narayan1, Wei Wu1, Russell T Toll1, Sharon Naparstek1, Carlo De Los Angeles1, Parker Longwell1, Emmanuel Shpigel1, Jennifer Newman1, Duna Abu-Amara1, Charles Marmar1, Amit Etkin1.   

Abstract

OBJECTIVE: A major challenge in understanding and treating posttraumatic stress disorder (PTSD) is its clinical heterogeneity, which is likely determined by various neurobiological perturbations. This heterogeneity likely also reduces the effectiveness of standard group comparison approaches. The authors tested whether a statistical approach aimed at identifying individual-level neuroimaging abnormalities that are more prevalent in case subjects than in control subjects could reveal new clinically meaningful insights into the heterogeneity of PTSD.
METHODS: Resting-state functional MRI data were recorded from 87 unmedicated PTSD case subjects and 105 war zone-exposed healthy control subjects. Abnormalities were modeled using tolerance intervals, which referenced the distribution of healthy control subjects as the "normative population." Out-of-norm functional connectivity values were examined for enrichment in cases and then used in a clustering analysis to identify biologically defined PTSD subgroups based on their abnormality profiles.
RESULTS: The authors identified two subgroups among PTSD cases, each with a distinct pattern of functional connectivity abnormalities with respect to healthy control subjects. Subgroups differed clinically on levels of reexperiencing symptoms and improved case-control discriminability and were detectable using independently recorded resting-state EEG data.
CONCLUSIONS: The results provide proof of concept for the utility of abnormality-based approaches for studying heterogeneity within clinical populations. Such approaches, applied not only to neuroimaging data, may allow detection of subpopulations with distinct biological signatures so that further clinical and mechanistic investigations can be focused on more biologically homogeneous subgroups.

Entities:  

Keywords:  Models/Theories Of Psychiatry; Posttraumatic Stress Disorder

Year:  2019        PMID: 31838870     DOI: 10.1176/appi.ajp.2019.19010060

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  5 in total

1.  Reversed patterns of resting state functional connectivity for females vs. males in posttraumatic stress disorder.

Authors:  Liat Helpman; Xi Zhu; Sigal Zilcha-Mano; Benjamin Suarez-Jimenez; Amit Lazarov; Bret Rutherford; Yuval Neria
Journal:  Neurobiol Stress       Date:  2021-09-01

Review 2.  Translating Across Circuits and Genetics Toward Progress in Fear- and Anxiety-Related Disorders.

Authors:  Kerry J Ressler
Journal:  Am J Psychiatry       Date:  2020-03-01       Impact factor: 18.112

3.  Developing Multimodal Dynamic Functional Connectivity as a Neuroimaging Biomarker.

Authors:  Suprateek Kundu; Jin Ming; Jennifer Stevens
Journal:  Brain Connect       Date:  2021-04-13

4.  Identification of psychiatric disorder subtypes from functional connectivity patterns in resting-state electroencephalography.

Authors:  Yu Zhang; Wei Wu; Russell T Toll; Sharon Naparstek; Adi Maron-Katz; Mallissa Watts; Joseph Gordon; Jisoo Jeong; Laura Astolfi; Emmanuel Shpigel; Parker Longwell; Kamron Sarhadi; Dawlat El-Said; Yuanqing Li; Crystal Cooper; Cherise Chin-Fatt; Martijn Arns; Madeleine S Goodkind; Madhukar H Trivedi; Charles R Marmar; Amit Etkin
Journal:  Nat Biomed Eng       Date:  2020-10-19       Impact factor: 25.671

5.  CRF serum levels differentiate PTSD from healthy controls and TBI in military veterans.

Authors:  Jaime Ramos-Cejudo; Afia Genfi; Duna Abu-Amara; Ludovic Debure; Meng Qian; Eugene Laska; Carole Siegel; Nicholas Milton; Jennifer Newman; Esther Blessing; Meng Li; Amit Etkin; Charles R Marmar; Silvia Fossati
Journal:  Psychiatr Res Clin Pract       Date:  2021-06-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.